![Topiramate Normalizes Hippocampal NPY-LI in Flinders Sensitive Line 'Depressed' Rats and Upregulates NPY, Galanin, and CRH-LI in the Hypothalamus: Implications for Mood-Stabilizing and Weight Loss-Inducing Effects | Neuropsychopharmacology Topiramate Normalizes Hippocampal NPY-LI in Flinders Sensitive Line 'Depressed' Rats and Upregulates NPY, Galanin, and CRH-LI in the Hypothalamus: Implications for Mood-Stabilizing and Weight Loss-Inducing Effects | Neuropsychopharmacology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsj.npp.1300178/MediaObjects/41386_2003_Article_BF1300178_Fig1_HTML.jpg)
Topiramate Normalizes Hippocampal NPY-LI in Flinders Sensitive Line 'Depressed' Rats and Upregulates NPY, Galanin, and CRH-LI in the Hypothalamus: Implications for Mood-Stabilizing and Weight Loss-Inducing Effects | Neuropsychopharmacology
![Frontiers | The Efficacy and Safety of Topiramate in the Prevention of Pediatric Migraine: An Update Meta-Analysis Frontiers | The Efficacy and Safety of Topiramate in the Prevention of Pediatric Migraine: An Update Meta-Analysis](https://www.frontiersin.org/files/MyHome%20Article%20Library/503975/503975_Thumb_400.jpg)
Frontiers | The Efficacy and Safety of Topiramate in the Prevention of Pediatric Migraine: An Update Meta-Analysis
![Outcomes and safety of concomitant topiramate or metformin for antipsychotics-induced obesity: a randomized-controlled trial | Annals of General Psychiatry | Full Text Outcomes and safety of concomitant topiramate or metformin for antipsychotics-induced obesity: a randomized-controlled trial | Annals of General Psychiatry | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12991-020-00319-x/MediaObjects/12991_2020_319_Fig1_HTML.png)
Outcomes and safety of concomitant topiramate or metformin for antipsychotics-induced obesity: a randomized-controlled trial | Annals of General Psychiatry | Full Text
![Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial - The Lancet Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial - The Lancet](https://www.thelancet.com/cms/attachment/2001011946/2003801181/gr1.gif)
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial - The Lancet
![Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison | Semantic Scholar Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/587882ec415333b17ee82a97530445fcd0347d92/3-Table1-1.png)